Charged surfactants induce a non-fibrillar aggregation pathway of amyloid-beta peptide

Journal of Peptide Science

Volumn 19, Issue 9, 2013, Pages 581-587

  Loureiro, Joana A ^a   Rocha, Sandra ^a   Pereira, Maria Do Carmo ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Aggregation; Alzheimer; Beta amyloid; Oligomers; Surfactants

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CATIONIC SURFACTANT; THIOFLAVINE;

ARTICLE; BETA SHEET; MICELLE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; STATIC ELECTRICITY;

AGGREGATION; ALZHEIMER; BETA AMYLOID; OLIGOMERS; SURFACTANTS;

AMYLOID; AMYLOID BETA-PEPTIDES; CETRIMONIUM COMPOUNDS; FLUORESCENT DYES; FOURIER ANALYSIS; GLUCOSIDES; HUMANS; KINETICS; MICELLES; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; SODIUM DODECYL SULFATE; SURFACE-ACTIVE AGENTS; THIAZOLES;

EID: 84882251930     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2535     Document Type: Article

References (37)

1. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-356.
2. Clippingdale AB, Wade JD, Barrow CJ. The amyloid-beta peptide and its role in Alzheimer's disease. J. Pept. Sci. 2001; 5: 227-249.
3. Ladiwala AR, Litt J, Kane RS, Aucoin DS, Smith SO, Ranjan S, Davis J, Van Nostrand WE, Tessier PM. Conformational differences between two amyloid beta oligomers of similar size and dissimilar toxicity. J. Biol. Chem. 2012; 287: 24765-24773.
4. Suh YH, Checler F. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol. Rev. 2002; 54: 469-525.
5. Andreasen N, Blennow K. Beta-amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease. Peptides 2002; 23: 1205-1214.
6. Citron M, Diehl TS, Gordon G, Biere AL, Seubert P, Selkoe DJ. Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities. Proc. Nat. Acad. Sci. U.S.A. 1996; 93: 13170-13175.
7. Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, Reardon IM, Zurcherneely HA, Heinrikson RL, Ball MJ, Greenberg BD. Structural alterations in the backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's-disease. J. Biol. Chem. 1993; 268: 3072-3083.
8. Evin G, Weidemann A. Biogenesis and metabolism of Alzheimer's disease A beta amyloid peptides. Peptides 2002; 23: 1285-1297.
9. Stine WB, Dahlgren KN, Krafft GA, LaDu MJ. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J. Biol. Chem. 2003; 278: 11612-11622.
10. Rangachari V, Moore BD, Reed DK, Sonoda LK, Bridges AW, Conboy E, Hartigan D, Rosenberry TL. Amyloid-beta (1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate. Biochemistry-US 2007; 46: 12451-12462.
11. Tew DJ, Bottomley SP, Smith DP, Ciccotosto GD, Babon J, Hinds MG, Masters CL, Cappai R, Barnham KJ. Stabilization of neurotoxic soluble beta-sheet-rich conformations of the Alzheimer's disease amyloid-beta peptide. Biophys. J. 2008; 94: 2752-2766.
12. Ghavami M, Rezaei M, Ejtehadi R, Lotfi M, Shokrgozar MA, Abd Emamy B, Raush J, Mahmoudi M. Physiological temperature has a crucial role in amyloid beta in the absence and presence of hydrophobic and hydrophilic nanoparticles. ACS Chem. Neurosci. 2012; 4: 375-378.
13. Marcinowski KJ, Shao H, Clancy EL, Zagorski MG. Solution structure model of residues 1-28 of the amyloid beta peptide when bound to micelles. J. Am. Chem. Soc. 1998; 120: 11082-11091.
14. Coles M, Bicknell W, Watson AA, Fairlie DP, Craik DJ. Solution structure of amyloid beta-peptide (1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry-US 1998; 37: 11064-11077.
15. Shao HY, Jao SC, Ma K, Zagorski MG. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. J. Mol. Biol. 1999; 285: 755-773.
16. Sabate R, Estelrich J. Stimulatory and inhibitory effects of alkyl bromide surfactants on beta-amyloid fibrillogenesis. Langmuir 2005; 21: 6944-6949.
17. Rangachari V, Reed DK, Moore BD, Rosenberry TL. Secondary structure and interfacial aggregation of amyloid-beta (1-40) on sodium dodecyl sulfate micelles. Biochemistry-US 2006; 45: 8639-8648.
18. Cao MW, Han YC, Wang JB, Wang YL. Modulation of fibrillogenesis of amyloid beta(1-40) peptide with cationic gemini surfactant. J. Phys. Chem. B 2007; 111: 13436-13443.
19. Wahlstrom A, Hugonin L, Peralvarez-Marin A, Jarvet J, Graslund A. Secondary structure conversions of Alzheimer's A beta(1-40) peptide induced by membrane-mimicking detergents. FEBS J. 2008; 275: 5117-5128.
20. Rocha S, Loureiro JA, Brezesinski G, Pereira MC. Peptide-surfactant interactions: consequences for the amyloid-beta structure. Biochem. Biophys. Res. Commun. 2012; 420: 136-140.
21. Otzen DE. Amyloid formation in surfactants and alcohols: Membrane mimetics or structural switchers? Curr. Protein Pept. Sci. 2010; 11: 355-371.
22. Otzen D. Protein-surfactant interactions: A tale of many states. BbA-Proteins Proteomics 2011; 1814: 562-591.
23. Rocha S, Lucio M, Pereira MC, Reis S, Brezesinski G. The conformation of fusogenic B18 peptide in surfactant solutions. J. Pept. Sci. 2008; 14: 436-441.
24. Friedman R, Caflisch A. Surfactant effects on amyloid aggregation kinetics. J. Mol. Biol. 2011; 414: 303-312.
25. Nilsson MR. Techniques to study amyloid fibril formation in vitro. Methods 2004; 34: 151-160.
26. Rocha S, Cardoso I, Börner H, Pereira MC, Saraiva MJ, Coelho M. Design and biological activity of beta-sheet breaker peptide conjugates. Biochem. Biophys. Res. Commun. 2009; 380: 397-401.
27. Baquerizo I, Ruiz MA, Holgado JA, Cabrerizo GV. Measurement of dynamic surface tension to determine critical micellar concentration in lipophilic silicone surfactants. Il Farmaco 2000; 55: 583-589.
28. Jameson LP, Smith NW, Dzyuba SV. Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid self-assembly. ACS Chem. Neurosci. 2012; 11: 807-819.
29. Hellstrand E, Boland B, Walsh DM, Linse S. Amyloid beta-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem. Neurosci. 2009; 1: 13-18.
30. Chen Z, Krause G, Reif B. Structure and orientation of peptide inhibitors bound to beta-amyloid fibrils. J. Mol. Biol. 2005; 354: 760-776.
31. Klement K, Wieligmann K, Meinhardt J, Hortschansky P, Richter W, Fandrich M. Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer's A beta(1-40) amyloid fibrils. J. Mol. Biol. 2007; 373: 1321-1333.
32. Cerf E, Sarroukh R, Tamamizu-Kato S, Breydo L, Derclaye S, Dufrêne YF, Narayanaswami V, Goormaghtigh E, Ruysschaert JM, Raussens V. Antiparallel β-sheet: a signature structure of the oligomeric amyloid β-peptide. Biochem. J. 2009; 421: 415-423.
33. Liao YH, Chang YJ, Yoshiike Y, Chang YC, Chen YR. Negatively charged gold nanoparticles inhibit Alzheimer's amyloid-fibrillization, induce fibril dissociation, and Mitigate Neurotoxicity. Small 2012; 8: 3631-3639.
34. Saraiva AM, Cardoso I, Pereira MC, Coelho MA, Saraiva MJ, Möhwald H, Brezesinski G. Controlling amyloid-beta peptide(1-42) oligomerization and toxicity by fluorinated nanoparticles. Chembiochem 2010; 13: 1905-1913.
35. Saraiva AM, Cardoso I, Saraiva MJ, Tauer K, Pereira MC, Coelho MA, Möhwald H, Brezesinski G. Randomization of amyloid-beta-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity. Macromol. Biosci. 2010; 10: 1152-63.
36. Baldwin RL. How hofmeister ion interactions affect protein stability. Biophys. J. 1996; 71: 2056-2063.
37. Riès-kautt M, Ducruix A. Inferences drawn from physicochemical studies of crystallogenesis and precrystalline state. Methods in Enzymol. 1997; 276: 23-59.